{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:01:59Z","timestamp":1790485319192,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL098046"],"award-info":[{"award-number":["HL098046"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016990","name":"Hellenic Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.amjcard.2012.05.038","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:02:30Z","timestamp":1340841750000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparison and Effectiveness of Regadenoson Versus Dipyridamole on Stress Electrocardiographic Changes During Positron Emission Tomography Evaluation of Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"110","author":[{"given":"Paco E.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis","family":"Pozios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lio","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.W.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Roselle","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore P.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.05.038_bib1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0735-1097(90)90237-J","article-title":"Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging","volume":"15","author":"Hutchins","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2967\/jnumed.111.096156","article-title":"PET\/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"53","author":"Bravo","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.amjcard.2012.05.038_bib4","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s00259-011-1853-6","article-title":"Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET","volume":"38","author":"Goudarzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.amjcard.2012.05.038_bib5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nuclcard.2007.02.016","article-title":"Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans","volume":"14","author":"Lieu","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2005.02.050","article-title":"Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy","volume":"151","author":"Sorajja","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.05.038_bib7","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","article-title":"Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging","volume":"46","author":"Hendel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcmg.2008.02.003","article-title":"Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results","volume":"1","author":"Cerqueira","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2012.05.038_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3565(24)29370-8","article-title":"Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists","volume":"298","author":"Gao","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjcard.2012.05.038_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-8703(94)90117-1","article-title":"ST-segment depression during adenosine infusion as a predictor of myocardial ischemia","volume":"127","author":"Marshall","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.05.038_bib12","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1161\/01.CIR.96.12.4268","article-title":"Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy","volume":"96","author":"Lazzeroni","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.05.038_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0735-1097(88)90353-1","article-title":"Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants","volume":"12","author":"Chambers","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1067\/mnc.2002.127625","article-title":"Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging","volume":"10","author":"Abbott","year":"2003","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.038_bib15","first-page":"1095","article-title":"Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging","volume":"46","author":"Chow","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.amjcard.2012.05.038_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.CIR.57.6.1103","article-title":"Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia","volume":"57","author":"Becker","year":"1978","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912014397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912014397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:24:00Z","timestamp":1757571840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912014397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0002914912014397"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.05.038","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison and Effectiveness of Regadenoson Versus Dipyridamole on Stress Electrocardiographic Changes During Positron Emission Tomography Evaluation of Patients With Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}